Brain structural network modular and connectivity alterations in subtypes of patients with migraine and medication

Chi-Wen Jao1, Yu-Te Wu2, Wei-Hung Chen3

  • 1Institute of Biophotonics, National Yang Ming Chiao Tung University, Taipei, Taiwan; Department of Research, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.

PubMed

Insights

This study reveals significant brain structural network differences in chronic migraine (CM) and medication overuse headache (MOH) compared to episodic migraine (EM) and healthy controls. CM and MOH patients exhibit less efficient, less centralized, and abnormally segregated brain networks.

Area of Science:

  • Neurology
  • Neuroimaging
  • Brain Network Analysis

Background:

  • Migraine is a prevalent neurological disorder classified into episodic migraine (EM) and chronic migraine (CM).
  • Medication overuse headache (MOH) is a chronic headache resulting from painkiller overuse.
  • Understanding brain structural differences across these headache types is crucial for targeted treatments.

Purpose of the Study:

  • To compare regional cortical morphology and brain structural network changes in EM, CM, and MOH patients versus healthy controls (HC).
  • To investigate alterations in cortical thickness and network connectivity patterns.

Main Methods:

  • Sixty participants (20 each in EM, CM, MOH groups, plus HC) underwent neuroimaging analysis.
  • Cortical thickness (CTs) and brain structural network properties (connectivity, efficiency, centrality) were assessed.

Main Results:

  • EM showed CTs thinning in the left limbic areas.
  • CM and MOH exhibited widespread CTs thinning, reduced intra-lobe connectivity, and decreased inter-limbic connectivity.
  • CM and MOH displayed increased inter-frontal and inter-parietal connectivity, suggesting compensatory mechanisms.
  • Both CM and MOH groups had reduced global efficiency and betweenness centrality, with MOH most affected.

Conclusions:

  • Chronic migraine and medication overuse headache are associated with less efficient, less centralized, and abnormally segregated brain networks.
  • These findings highlight distinct structural network alterations in more severe headache forms.
  • Aberrant brain networks in CM and MOH may underlie their debilitating nature and resistance to treatment.

Related Concept Videos

Brainstem01:19

Brainstem

The brainstem, located inferior to the brain and superior to the spinal cord, serves as a bridge between the cerebrum and the spinal cord. It plays a vital role in relaying information and controlling critical life functions. It comprises three primary regions: the midbrain, pons, and medulla oblongata.
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Brain Imaging01:14

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...